Review ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 54 | Issue 3 | 2020 | pp. 517–525Open access
Pharm D Program: Is it Necessary in BRICS?
- 1*,
- 2,
- 2,
- 2,
- 1
- 1 College of Pharmacy, Jinan University, Guangzhou, CHINA.
- 2 Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Pei Yu
College of Pharmacy, Jinan University, Guangzhou, CHINA.
Email: pennypeiyu@163.com
Copyright: © 2020 Manuscript Technomedia. This is an open access article.
- Published:
- Aug 22, 2020
- Received:
- Sep 30, 2019
- Accepted:
- Feb 26, 2020
How to cite
Yu, P., Wilson, B. J., Bobbins, A. C., Srinivas, S. C., & Yin, G. (2020). Pharm D Program: Is it Necessary in BRICS? Indian Journal of Pharmaceutical Education and Research, 54(3), 517–525. https://doi.org/10.5530/ijper.54.3.100
Abstract
The various trajectories of the development of the Doctor of Pharmacy (Pharm D) programs in BRICS countries were reviewed individually, showing the progress of Pharm D programs in each context. Evidence from developed countries indicates that Pharm D programs have contributed towards the positive development of public health and a country’s local health requirements, with well-trained clinical pharmacists having a key role in the health and economic development of these emerging powers. The health systems of BRICS countries are heavily challenged with a dual burden of disease, weak health infrastructure and public health initiatives. Thus, not only will the development of Pharm D programs in BRICS countries strengthen pharmacy education contributing to a pharmacy workforce more readily able to target health-related problems, demographic and epidemiological shifts; but will also better equip public health systems with more patient-centered pharmaceutical care necessary for evidence-based, individualized and cost-effective healthcare.
Keywords
Subject
Article metadata
| Title | Pharm D Program: Is it Necessary in BRICS? |
|---|---|
| Authors | Pei Yu; Beverley Joy Wilson; Amy Claire Bobbins; Sunitha Chandrasekhar Srinivas; Gang Yin |
| Affiliations | College of Pharmacy, Jinan University, Guangzhou, CHINA.; Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA. |
| Corresponding author | pennypeiyu@163.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 54, Issue 3 (2020) |
Also in this issue
- Is Covid-19 Sibling of SARS and MERS? A Review on: Novel Covid-19pp. 491–495
- Caspase Activators: Phytochemicals with Apoptotic Properties Targeting Cancer, a Health Care Strategy to Combat this Diseasepp. 496–508
- Therapeutic Potential of Chymase Inhibitors in Cardiovascular Diseases: An Overviewpp. 509–516
- Biomaterials in 3D Printing: A Special Emphasis on Nanocellulosepp. 526–540
- Novel Oral Drug Delivery Systems for Steroids: Overview and Recent Updatespp. 541–549
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026